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 Purpose: To examine whether U.S. radiologists’ interpretive volume 
affects their screening mammography performance.
 Materials and 
Methods: 
Annual interpretive volume measures (total, screening, di-
agnostic, and screening focus [ratio of screening to diag-
nostic mammograms]) were collected for 120 radiologists 
in the Breast Cancer Surveillance Consortium (BCSC) who 
interpreted 783 965 screening mammograms from 2002 to 
2006. Volume measures in 1 year were examined by using 
multivariate logistic regression relative to screening sen-
sitivity, false-positive rates, and cancer detection rate the 
next year. BCSC registries and the Statistical Coordinat-
ing Center received institutional review board approval for 
active or passive consenting processes and a Federal Cer-
tifi cate of Confi dentiality and other protections for partici-
pating women, physicians, and facilities. All procedures 
were compliant with the terms of the Health Insurance 
Portability and Accountability Act.
 Results: Mean sensitivity was 85.2% (95% confi dence interval [CI]: 
83.7%, 86.6%) and was signifi cantly lower for radiologists 
with a greater screening focus ( P = .023) but did not sig-
nifi cantly differ by total ( P = .47), screening ( P = .33), or 
diagnostic ( P = .23) volume. The mean false-positive rate 
was 9.1% (95% CI: 8.1%, 10.1%), with rates signifi cantly 
higher for radiologists who had the lowest total ( P = .008) 
and screening ( P = .015) volumes. Radiologists with low 
diagnostic volume ( P = .004 and  P = .008) and a greater 
screening focus ( P = .003 and  P = .002) had signifi cantly 
lower false-positive and cancer detection rates, respec-
tively. Median invasive tumor size and proportion of can-
cers detected at early stages did not vary by volume.
 Conclusion: Increasing minimum interpretive volume requirements in 
the United States while adding a minimal requirement 
for diagnostic interpretation could reduce the number 
of false-positive work-ups without hindering cancer detec-
tion. These results provide detailed associations between 
mammography volumes and performance for policymak-
ers to consider along with workforce, practice organiza-
tion, and access issues and radiologist experience when 
reevaluating requirements.
 q RSNA, 2011
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or passive consenting processes and a 
Federal Certifi cate of Confi dentiality 
and other protections for participat-
ing women, physicians, and facilities. 
All procedures are compliant with the 
terms of the Health Insurance Portabil-
ity and Accountability Act ( 16 ). 
 Sample Group 
 This study included six BCSC mammog-
raphy registries (in California, North 
Carolina, New Hampshire, Vermont, 
Washington, and New Mexico) that have 
previously been described ( 12,13 ). BCSC 
registries collect information on mam-
mography examinations performed at 
participating facilities in their defi ned 
catchment areas and link this informa-
tion to state tumor registries or regional 
Surveillance Epidemiology and End Re-
sults programs to obtain population-
based cancer data. Demographic and 
breast cancer risk factor data are col-
lected by using a self-reported question-
naire completed at each mammography 
examination. 
readers have lower false-positive rates 
with no sensitivity difference. Prior stud-
ies had limitations that could account 
for the inconsistencies, including differ-
ent approaches for measuring volume 
(self report vs observational data), study 
designs, and settings (test set vs clinical 
practice), performance measures, cova-
riates, and modeling methods. In a small 
Canadian study ( 11 ), abnormal interpre-
tations were lower and CDRs were higher 
for radiologists performing between 2000 
and 3999 interpretations annually com-
pared with those for radiologists per-
forming fewer than 2000 interpretations 
annually. Two confl icting studies used 
overlapping populations from the Breast 
Cancer Surveillance Consortium (BCSC) 
( 12,13 ). Barlow et al ( 14 ) found that 
higher self-reported volume was associ-
ated with greater sensitivity and higher 
false-positive rates. Smith-Bindman et al 
( 15 ) defi ned volume by measured num-
ber of BCSC examinations and found 
that higher volume was associated with 
lower false-positive rates, with no impact 
on sensitivity. Barlow et al included no 
validation of self-reported volume, and 
Smith-Bindman et al did not capture 
volume from mammograms interpreted 
at non-BCSC facilities. Inconsistent fi nd-
ings with overlapping study populations 
highlight how different conclusions may 
be drawn by using different analytic meth-
ods and measures. 
 Our purpose was to examine whether 
U.S. radiologists’ interpretive volume 
affects their screening mammography 
performance. 
 Materials and Methods 
 BCSC registries and the Statistical Coor-
dinating Center have received institu-
tional review board approval for active 
 Mammography is the only screen-ing test that has been demon-strated in trials to reduce breast 
cancer mortality ( 1 ). An Institute of 
Medicine report ( 2 ) noted that while the 
technical quality of mammography has 
improved since implementation of the 
Mammography Quality Standards Act 
of 1992 (MQSA), optimal sensitivity and 
specifi city have not yet been achieved 
( 3 ). The report called for additional re-
search on the relationship between inter-
pretive volume and performance ( 2 ). 
 Compared with the United States, 
other countries with established screen-
ing mammography programs have lower 
false-positive rates but comparable can-
cer detection rates (CDRs) ( 4–6 ). Hy-
pothesized reasons include the shorter 
screening intervals and the lower in-
terpretive volume requirements in the 
United States (960 mammograms every 
2 years—fi ve- to 10-fold lower than in 
other countries) ( 7–9 ). 
 Mammography performance and 
volume findings, though inconsistent 
( 10 ), generally suggest that higher-volume 
 Implication for Patient Care 
 Our results provide detailed asso- n
ciations between mammography 
volumes and performance for 
policymakers to consider along 
with workforce, practice organi-
zation, and access issues and 
radiologist experience when 
reevaluating requirements. 
 Advances in Knowledge 
 We found no clear association  n
between interpretive volume and 
sensitivity. 
 Performance across radiologists  n
within volume levels had wide, 
unexplained variability, reinforc-
ing the ideas that the volume-
performance relationship is com-
plex and several factors may 
infl uence it. 
 Screening performance is unlikely  n
to be affected by volume alone, 
but rather by a balance in the 
interpreted examination compo-
sition; radiologists with a greater 
screening focus had signifi cantly 
lower sensitivity ( P = .023), 
cancer detection ( P = .002), and 
false-positive rates ( P = .003). 
 Radiologists with higher annual  n
volumes had clinically and statis-
tically signifi cantly lower false-
positive rates with similar sensi-
tivities as their colleagues with 
lower annual volumes. 




 BCSC = Breast Cancer Surveillance Consortium 
 CDR = cancer detection rate 
 CI = confi dence interval 
 DCIS = ductal carcinoma in situ 
 MQSA = Mammography Quality Standards Act of 1992 
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interpreted. Performance measures were 
derived from 783 965 screening examina-
tions (in 476 079 unique women) inter-
preted between 2002 and 2006; these 
included mammograms in asymptom-
atic women with a routine screening 
indication. 
 Analysis 
 We calculated crude performance mea-
sures according to categoric versions of 
the four continuous volume measures. 
The association between continuous vol-
ume measures and screening perfor-
mance was modeled by using restricted 
cubic smoothing splines ( 20 ), which per-
mit a fl exible shape while avoiding arbi-
trary cutpoints. We computed the smooth-
ing splines with three knots placed at 
the 33rd, 50th, and 67th percentiles of 
the volume distribution. Volume distri-
butions were heavily skewed with sparse 
information in the tails; therefore, we 
restricted each volume range before 
fi tting the logistic regression models. 
Estimations were limited to a total vol-
ume of 6000 or fewer mammograms, 
a screening volume of 5000 or fewer 
mammograms, a diagnostic volume of 
2000 or fewer mammograms, and a 
screening focus of 65% or greater to 
ensure that we had adequate infor-
mation for stable estimates for model 
parameters. 
 To measure the potential tradeoff 
between sensitivity and false-positive 
rates, we calculated the number of women 
recalled for each cancer detected. To 
adjust for differing case-mix distribu-
tions across radiologists, we computed 
adjusted performance measures by using 
internal standardization ( 21 ). Internal 
standardization works by reweighting 
each mammogram according to the rela-
tive difference between the radiologist-
specifi c distribution of potential con-
founders (age and time since last mam-
mogram) and the corresponding distri-
bution in the overall analytic sample. 
Intuitively, this process results in calcu-
lated performance measures for radi-
ologists had their case mixes been the 
same as that in the overall population. 
Standardizing removes differences in 
the potential confounders across radiolo-
gists and therefore removes the potential 
basis of the proportion of screening mam-
mograms where indications were observed 
for that reader. 
 For each year, we also computed the 
“screening focus” for each reader, defi ned 
as the percentage of total mammograms 
that were screening examinations. 
 All volume measures for each year 
were linked to screening performance in 
the following year (eg, volume in 2005 
was linked to performance in 2006). 
Performance data were based solely on 
screening mammograms interpreted 
within BCSC facilities, because although 
volume data were available from non-BCSC 
facilities, linkage to cancer follow-up data 
was not possible for mammograms in-
terpreted at non-BCSC facilities. Only 4% 
(19 of 481) of our study’s reader-years 
included radiologists who interpreted at 
non-BCSC facilities; among these read-
ers, a mean of 54% of their total volume 
comprised non-BCSC mammograms. 
 Women given a diagnosis of inva-
sive carcinoma or ductal carcinoma in 
situ (DCIS) within 1 year of the screen-
ing mammogram and before their next 
screening mammogram were included 
as representing breast cancer cases ( 19 ). 
Tumor characteristics were collected 
from tumor registries and pathology da-
tabases. We defi ned early stage cancers 
in three ways ( 19 ):  (a) DCIS or invasive 
cancer that was 10 mm or smaller,  (b) 
node-negative invasive cancer or DCIS 
that was 10 mm or smaller, and  (c) node-
negative invasive cancer or DCIS that 
was smaller than 15 mm. 
 Performance measures included sen-
sitivity, false-positive rate, and CDR. 
Sensitivity was defi ned as the propor-
tion of screening examinations inter-
preted as positive (defi ned as Breast 
Imaging Reporting and Data System 
category 0 [needs additional assessment], 
category 4 [suspicious abnormality], or 
category 5 [highly suggestive of ma-
lignancy]) among all women who were 
given a diagnosis of breast cancer within 
the 1-year follow-up period. False-positive 
rate was defi ned as the proportion of 
positive screening examinations among 
all women without a breast cancer di-
agnosis within the follow-up period. CDR 
was defi ned as the number of cancers de-
tected per 1000 screening mammograms 
 BCSC radiologists who interpreted 
screening mammograms between 2005 
and 2006 were invited to complete a 
self-administered mailed survey, as pre-
viously described ( 17 ); 214 radiologists 
completed it. The survey asked radiolo-
gists to indicate all facilities (outside 
the BCSC) at which they interpreted 
mammograms between 2001 and 2005. 
Registry staff members contacted non-
BCSC facilities and collected complete 
volume information for all radiologists. 
Our fi nal study sample included 120 ra-
diologists with a mean of 4.0 years of 
volume measures, resulting in 481 to-
tal reader-years of data for the analytic 
sample; 91% of radiologists (109 of 
120) interpreted mammograms at only 
BCSC facilities. The demographic char-
acteristics, time spent in breast imag-
ing, and experience of the radiologists 
included in the analytic sample were 
similar to those of the radiologists in-
cluded in the original sample (Table E1 
[online]). 
 Interpretive volume, collected for 
each radiologist by facility and examina-
tion year, was summed across all facili-
ties to obtain the annual volume for each 
radiologist. We collected total, screen-
ing, and diagnostic volumes for each 
year. We included mammograms in the 
volume estimate only if the radiologist 
was the primary reader. The radiolo-
gist’s indication for the examination was 
used to categorize screening and diag-
nostic volumes. Diagnostic examinations 
included additional evaluation of a prior 
mammogram, short-interval follow-up, 
or evaluation of a breast symptom or 
mammographic abnormality. Total vol-
ume included all screening and diagnos-
tic examinations, with screening and 
diagnostic mammograms interpreted by 
the same radiologist on the same day 
counted as one examination. The latter 
defi nition differs from that used in the 
Breast Imaging Reporting and Data Sys-
tem audits ( 18 ), where mammograms 
performed on the same day contribute 
independently to volume. These two 
approaches yielded little difference in 
calculating total volume. For the 2.5% 
of mammograms with missing indica-
tions, we attributed their indication to 
screening or diagnostic volume on the 
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 Table 1 
 Characteristics of Radiologists according to Total Interpretive Volume 
Characteristic Total * 
Mean Annual Total Volume (No. of Mammograms)
480–999 1000–1499 1500–1999 2000–2999 3000–4999   5000
No. of radiologists * 120 20 (17) 25 (21) 19 (16) 29 (24) 16 (13) 11 (9)
Age at survey (y)
  , 45 31 (26) 30 28 42 17 25 9
 45–54 33 (28) 20 24 32 28 44 18
   55 56 (47) 50 48 26 55 31 73
Sex
 Male 80 (67) 65 80 58 72 50 64
 Female 40 (33) 35 20 42 28 50 36
Work full time (  40 h/wk)
 No 30 (25) 30 24 22 25 25 27
 Yes 88 (75 ) 70 76 78 75 75 73
Primary affi liation with academic medical center
 No affi liation 90 (76) 65 88 79 86 69 40
 Adjunct 7 (6) 0 8 5 3 0 30
 Primary 22 (18) 35 4 16 10 31 30
Experience
 Time since graduation from residency (y)
   , 10 19 (16) 25 20 21 10 13 0
  10–19 37 (31) 20 32 53 28 33 18
    20 63 (53) 55 48 26 62 53 82
 Combined variable of fellowship training and duration 
   of mammography interpretation (y )
  No fellowship,  , 10 19 (16) 35 20 32 0 6 0
  No fellowship, 10–19 38 (32) 15 36 42 45 19 18
  No fellowship,   20 53 (44) 50 44 16 45 50 73
  Fellowship,  , 10 3 (2) 0 0 0 3 13 0
  Fellowship,   10 7 (6) 0 0 11 7 13 9
 Time working in breast imaging (%)
   , 20 30 (26) 37 48 25 17 6 9
  20–39 29 (25) 21 28 44 28 19 0
  40–79 19 (16) 11 0 25 21 31 18
  80–100 38 (33) 32 24 6 34 44 73
Interpretive volume
 Mean annual screening volume (no. of mammograms)
  480–999 31 (26) 100 44 0 0 0 0
  1000–1499 19 (16) 0 56 26 0 0 0
  1500–1999 31 (26) 0 0 74 59 0 0
  2000–2999 18 (15) 0 0 0 41 31 9
    3000 21 (18) 0 0 0 0 69 91
 Mean annual diagnostic volume (no. of mammograms)
   , 100 15 (12) 50 12 5 0 6 0
  100–199 13 (11) 35 16 5 0 6 0
  200–299 30 (25) 15 48 42 24 0 0
  300–499 39 (32) 0 24 47 66 25 9
  500–999 12 (10) 0 0 0 10 44 18
    1000 11 (9) 0 0 0 0 19 73
Screening focus: mean annual percentage of all 
   examinations that are screening
  , 75 10 (8) 0 12 0 3 13 36
 75–79 14 (12) 10 8 21 7 6 27
 80–84 41 (34) 25 36 37 41 38 18
Table 1 (continues)
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impact of confounding. We then used gen-
eralized estimating equations to model 
the marginal association between the 
continuous adjusted performance mea-
sures and volume ( 20 ). Given the fl ex-
ibility provided by the restricted cubic 
spline framework, the estimated mean 
adjusted performance is presented 
graphically, along with pointwise 95% 
confidence intervals (CIs), with the 
curves being interpreted directly as the 
mean adjusted performance as a func-
tion of the volume measure.  P values 
for the estimated curves correspond to 
omnibus tests of whether there is any 
association between mean adjusted per-
formance and volume. Under the null 
hypothesis, there would be no associa-
tion, and the estimated relationship 
would be a fl at line. We stratifi ed by 
cancer status, fi tting separate models 
for each performance measure by us-
ing a binary outcome based on the ra-
diologist’s initial mammogram assess-
ment of positive or negative. Robust 
sandwich standard error estimates were 
calculated to ensure appropriate ac-
counting of correlation by the same 
radiologist ( 22 ). 
 Sensitivity analyses to examine the 
robustness of our results to various data 
and modeling assumptions included vary-
ing the number and location of the 
smoothing splines knots and individu-
ally excluding each registry to ensure 
that none overly infl uenced results. 
 All analyses were performed by us-
ing software (SAS, version 9.2; SAS In-
stitute, Cary, NC), including the restricted 
cubic splines programming ( 23 ). Two-
sided  P values less than .05 were con-
sidered to indicate a statistically signifi -
cant difference. 
 We simulated the effect of increas-
ing minimum interpretive volume in the 
United States on the basis of an estimated 
34 million women aged 40–79 years un-
dergoing screening each year ( 24–26 ) by 
using software (Stata, version 11; Stata, 
College Station, Tex). Cancer status was 
assigned on the basis of a cancer rate 
of 5.0 cancers per 1000 mammograms. 
Each woman was randomly assigned 
to one of the study radiologists, with 
the selection probability proportional to 
the reader’s observed volume. We used 
our primary multivariate model results 
to obtain the estimated probability of 
recall, on the basis of the woman’s can-
cer status and the reader’s observed 
volume, then randomly generated a 
mammogram result on the basis of the 
estimated probability of a recall. To 
simulate increasing the volume require-
ments, we generated a second mam-
mogram result for each woman. If the 
woman’s originally assigned radiologist 
had a volume greater than the threshold 
(ie, screening volume  . 1500 mammo-
grams), then the estimated probability 
of recall remained unchanged. If the 
original reader had a volume below the 
threshold, then the woman was randomly 
assigned to a reader with a volume above 
the threshold. We compared the simu-
lated test results against cancer status 
to estimate the number of cancers that 
were correctly recalled and the number 
of false-positive tests before and after 
reader reassignment. We based cost 
estimates on the mean Medicare reim-
bursement ( 27 ) of $107 per screening 
examination. We were unable to pro-
vide any estimates of cost savings for 
fewer missed cancers, because these 
costs are not well documented. 
 Results 
 We studied 120 radiologists with a 
median age of 54 years (range, 37–74 
years); most worked full time (75%), 
had 20 or more years of experience 
(53%), and had no fellowship train-
ing in breast imaging (92%) ( Table 1 ). 
Time spent in breast imaging varied, 
with 26% of radiologists working less 
than 20% and 33% working 80%–100% 
of their time in breast imaging. Most 
Characteristic Total * 
Mean Annual Total Volume (No. of Mammograms)
480–999 1000–1499 1500–1999 2000–2999 3000–4999   5000
 85–89 33 (28) 35 20 21 41 25 9
   90 22 (18) 30 24 21 7 19 9
Mean annual no. of facilities where interpreting
 1 44 (37) 30 44 42 34 31 36
  . 1 To 2 48 (40) 55 24 42 34 56 36
  . 2 To 3 16 (13) 15 24 11 14 6 0
  . 3 12 (10) 0 8 5 17 6 27
No. of years of volume and performance data
 1 10 (8) 25 4 11 3 6 0
 2 4 (3) 0 4 0 3 13 0
 3 21 (18) 10 24 21 7 25 27
 4 25 (21) 35 8 16 21 25 27
 5 60 (50) 30 60 53 66 31 45
 Note.—Unless otherwise specifi ed, data are column percentages. There were missing values for the work full time question ( n = 2), the primary affi liation with an academic medical center question 
( n = 1), the time since graduation from residency question ( n = 1), and the time working in breast imaging question ( n = 4). 
 * Data are numbers of radiologists, with percentages in parentheses. 
Table 1 (continued)
 Characteristics of Radiologists according to Total Interpretive Volume 
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Characteristics of women with screening 
mammograms are detailed according to 
their radiologists’ screening volume, di-
agnostic volume, and screening focus in 
Tables E3–E5 (online), respectively. 
 A total of 3321 cancers were de-
tected ( Table 3 ). Radiologists detected 
a median of 25 cancers (interquartile 
range, 11–46) over the study period. 
Among invasive cancers, median tumor 
size did not vary by radiologists’ volume; 
overall median tumor size was 13 mm 
(range,  , 1 to 130 mm). The propor-
tion of cancers detected at early stages 
did not vary across radiologist volume. 
Of 575 missed cancers, 507 (88%) were 
invasive, with a median size of 19 mm. 
 Unadjusted mean sensitivity was 
85.2% (95% CI: 83.7%, 86.6%), false-
positive rate was 9.1% (95% CI: 8.1%, 
10.1%), and CDR was 4.2 cancers per 
1000 mammograms (95% CI: 3.9, 4.6). 
Unadjusted screening sensitivity showed 
no consistent trends with any volume 
measure ( Table 4 ), except that sensi-
tivity decreased with higher screening 
percentage. 
than 100 (15 of 120) or 1000 or more 
(11 of 120) diagnostic mammograms an-
nually. Approximately 20% (24 of 120) 
of radiologists had a lower screening 
focus ( , 80% screening), and 18% (22 
of 120) had a greater screening focus 
(  90% screening). Radiologists with a 
lower screening focus had a higher to-
tal volume and were more commonly 
women, older, and more likely to have 
completed a breast imaging fellowship 
(Table E2 [online]). 
 Most of the screening mammograms 
included in the performance outcome 
measures had been obtained in women 
aged 40–59 years (60%), with fewer 
than 3% obtained in women younger 
than 40 years and fewer than 5% ob-
tained in women 80 years of age or older 
( Table 2 ). Sixteen percent of women 
had a fi rst-degree family history. Fewer 
than 5% of the mammograms were fi rst 
mammograms, and comparison fi lms 
were available for 86% of examina-
tions. Characteristics of women with 
screening mammograms did not differ 
by radiologist total volume ( Table 2 ). 
(61%) interpreted 1000–2999 mam-
mograms annually, with 9% interpret-
ing 5000 or more mammograms. The 
highest-volume readers had a lower 
screening focus and were more likely 
to have been in clinical practice for 20 
or more years and to have completed a 
breast imaging fellowship. 
 Mean annual screening volume ranged 
from 474 to 6255 mammograms (me-
dian, 1640 mammograms), and mean 
annual diagnostic volume ranged from 
41 to 3315 mammograms (median, 305 
mammograms). Mean annual screening 
volume was distributed as follows: 26% 
(31 of 120) of radiologists interpreted 
fewer than 1000 screening mammograms, 
16% (19 of 120) of radiologists inter-
preted 1000–1499 screening mammo-
grams, 26% (31 of 120) of radiologists 
interpreted 1500–1999 screening mam-
mograms, 15% (18 of 120) of radiolo-
gists interpreted 2000–2999 screening 
mammograms, and 18% (21 of 120) of 
radiologists interpreted 3000 or more 
screening mammograms. Approximately 
10% of radiologists interpreted fewer 
 Table 2 
 Characteristics of Women with Screening Mammograms between 2002 and 2006 in Relation to their Radiologists’ Mean Annual Total 
Interpretive Volume 
Parameter Total * 
Mean Annual Total Volume (No. of Mammograms)
480–999 1000–1499 1500–1999 2000–2999 3000–4999   5000
No. of mammograms * 783 965 39 072 (5.0) 89 857 (11.5) 91 901 (11.7) 217 693 (27.8) 154 385 (19.7) 191 057 (24.4)
Patient age (y)
  , 40 23 370 3.3 2.7 2.6 2.5 2.8 3.8
 40–49 220 779 29.1 26.4 26.2 26.1 28.7 31.7
 50–59 249 495 32.4 32.1 32.6 31.7 32.1 31.2
 60–69 155 608 20.0 20.2 20.2 21.1 19.4 18.5
 70–79 99 370 11.4 13.7 13.5 13.6 12.2 11.4
   80 35 343 3.9 4.8 5.0 5.0 4.8 3.5
First-degree family history of 
  breast cancer
 No 586 788 85.0 83.4 83.0 84.0 83.1 84.4
 Yes 113 559 15.0 16.6 17.0 16.0 16.9 15.6
 Unknown 83 618 9.5 10.0 8.2 9.9 19.1 6.5
Time since last mammogram (y)
 No previous mammogram 35 617 4.8 5.2 4.7 4.6 5.0 4.6
  , 2 629 544 82.5 83.2 84.2 84.1 84.1 85.4
 3–4 52 392 8.0 7.6 7.1 7.3 6.8 6.3
    5 29 783 4.7 4.0 4.0 4.0 4.1 3.6
 Unknown 36 629 5.2 2.0 3.2 4.1 6.1 6.0
Note.—Unless otherwise specifi ed, data are column percentages. Unknown percentages are not included in column percentages.
* Data are numbers of mammograms, and numbers in parentheses are percentages.
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 Table 3 
 Characteristics of Detected Tumors according to Radiologist Total Interpretive Volume 
Parameter Total * 
Mean Annual Total Volume (No. of Mammograms)
480–999 1000–1499 1500–1999 2000–2999 3000–4999   5000
No. of cancers detected * 3321 143 (4) 405 (12) 452 (14) 915 (28) 753 (23) 653 (20)
Cancer histologic type 
 DCIS 847 (26) 24 23 25 23 29 29
 Invasive 2470 (74) 76 77 75 77 71 71
Stage
 0 847 (26) 25 24 25 24 29 29
 I 1452 (45) 43 46 46 47 43 45
 II 722 (23) 20 21 25 23 22 22
 III 161 (5) 12 8 2 5 5 4
 IV 24 (1) 0 1 2 1 0 0
 Unknown 115 (3) 5 6 2 7 1 2
Cancer size (mm) † 
    5 275 (12) 17 12 9 12 12 12
 6–10 592 (25) 20 26 26 26 22 26
 11–15 597 (25) 24 27 27 24 27 21
 16–20 347 (15) 14 17 13 15 14 15
  . 20 561 (24) 26 19 25 23 25 25
 Unknown 98 (4) 7 7 5 3 2 3
Median cancer size (mm) † 13 13 13 14 13 13 13
Minimal cancer ‡ 
 DCIS or invasive cancer   10 mm 1714 (53) 53 52 52 53 53 56
 Invasive cancer  . 10 mm 1505 (47) 47 48 48 47 47 44
 Unknown 102 (3) 6 6 4 3 2 2
Early stage at diagnosis with defi nition 1
 DCIS or node-negative invasive 
  cancer   10 mm
1608 (50) 49 49 48 49 51 53
 Other 1607 (50) 51 51 52 51 49 47
 Unknown 106 (3) 6 5 4 4 1 2
Early stage at diagnosis with defi nition 2
 DCIS or node-negative invasive 
  cancer  , 15 mm
1945 (61) 62 60 59 59 62 62
 Other 1268 (39) 38 40 41 41 38 38
 Unknown 108 (3) 6 5 4 4 1 2
Axillary lymph node status † 
 Negative 1823 (75) 73 74 75 73 76 79
 Positive 593 (25) 27 26 25 27 24 21
 Unknown 54 (2) 5 4 2 3 0 1
Grade † 
 1: Well differentiated 597 (26) 21 27 26 24 29 27
 2: Moderately differentiated 1024 (45) 41 48 47 47 42 44
 3: Poorly differentiated 623 (27) 38 25 27 28 27 28
 4: Undifferentiated 22 (1) 0 0 0 1 2 1
 Unknown 204 (8) 16 13 8 9 6 4
Estrogen receptor status † 
 Negative 329 (15) 24 11 14 13 17 16
 Positive 1898 (85) 76 89 86 87 83 84
 Unknown 243 (10) 18 16 6 10 7 10
Note.—Unless otherwise specifi ed, data are column percentages. Unknown percentages are not included in column percentages.
* Data are numbers of cancers, with percentages in parentheses.
 † Invasive cancers only.
 ‡ Defi ned as in the report by Rosenberg et al (19).
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focus of less than 80% had higher 
sensitivity but recalled 23.8–27.0 women 
per cancer detected. 
 Figures 1–3 show the adjusted screen-
ing performance measures according 
to volume. Radiologists with lower vol-
ume and a greater screening focus had 
greater variability in all performance 
outcomes. Sensitivity estimates varied 
little across volume, with the excep-
tion of a lower sensitivity for radiolo-
gists with a greater screening focus ( P = 
.023). False-positive rates were signifi -
cantly lower for radiologists at neither 
radiologists with a screening focus of 
less than 80% (10.7% [95% CI: 8.9%, 
12.7%] and 4.8 [95% CI: 4.2, 5.4], 
respectively). 
 Overall, 22.3 women were recalled 
for each cancer detected—slightly fewer 
for radiologists with lower diagnostic 
volume and higher total and screening 
volumes. Radiologists with a screening 
focus of 90% or greater recalled a mean 
of 14.5 women for each cancer detected 
but had lower sensitivity than radiolo-
gists with lower screening focus per-
centages. Radiologists with a screening 
 Radiologists with lower screening 
volumes had higher false-positive rates, 
except radiologists who interpreted fewer 
than 480 mammograms annually, whose 
false-positive rates were lower but had 
wide 95% CIs. Interpreters with the 
highest diagnostic volume had higher 
false-positive rates. The lowest false-
positive rates were among radiologists 
with a screening focus of 90% or greater 
(5.6% [95% CI: 4.4%, 7.0%]), and 
this same group had the lowest CDRs 
(3.4 [95% CI: 2.7, 4.2]). The highest 
false-positive rates and CDRs were among 
 Table 4 
 Screening Performance Measures of False-Positive Rate, Sensitivity, and Number of Women Recalled per Cancer Detected according 
to Radiologist Interpretive Volume 
Parameter
Sensitivity False-Positive Rate
Mean CDR ‡ 
No. of Women 
Recalled per 
Cancer DetectedNo. of Reader-Years * Mean Value (%) † No. of Reader-Years * Mean Value (%) † 
Overall 464 85.2 (83.7, 86.6) 481 9.1 (8.1, 10.1) 4.2 (3.9, 4.6) 22.3
Annual total volume
  , 480 11 (2.4) 83.9 (72.5, 91.1) 15 (3.1) 7.7 (4.8, 12.1) 3.4 (2.4, 4.7) 19.3
 480–999 56 (12.1) 84.0 (79.2, 87.9) 63 (13.1) 11.0 (9.0, 13.4) 4.3 (3.6, 5.1) 27.0
 1000–1499 99 (21.3) 89.1 (85.7, 91.8) 104 (21.6) 11.2 (9.4, 13.3) 4.6 (4.2, 5.1) 25.9
 1500–1999 78 (16.8) 84.0 (79.7, 87.5) 79 (16.4) 8.3 (7.0, 9.9) 4.2 (3.5, 5.0) 20.8
 2000–2999 112 (24.1) 84.3 (81.5, 86.8) 112 (23.3) 8.3 (7.1, 9.6) 4.4 (3.9, 4.9) 20.5
 3000–4999 61 (13.2) 86.6 (83.1, 89.4) 61 (12.7) 8.4 (7.2, 9.7) 4.7 (3.9, 5.5) 20.2
    5000 47 (10.1) 84.0 (81.7, 86.1) 47 (9.8) 9.5 (7.0, 12.7) 3.6 (3.1, 4.2) 23.5
Annual screening volume
  , 480 14 (3.0) 88.7 (79.2, 94.1) 18 (3.7) 9.9 (6.4, 15.0) 4.2 (3.2, 5.5) 23.2
 480–999 91 (19.6) 84.2 (80.2, 87.5) 98 (20.4) 11.2 (9.6, 13.0) 4.3 (3.7, 4.9) 27.5
 1000–1499 98 (21.2) 88.8 (85.1, 91.7) 103 (21.4) 10.6 (9.1, 12.3) 4.9 (4.4, 5.5) 24.8
 1500–1999 85 (18.3) 84.0 (80.2, 87.2) 86 (17.9) 7.7 (6.4, 9.2) 4.1 (3.5, 4.7) 19.2
 2000–2999 96 (20.7) 84.5 (81.9, 86.8) 96 (20.0) 8.3 (7.4, 9.4) 4.4 (3.9, 5.0) 20.6
    3000 80 (17.2) 85.0 (82.4, 87.2) 80 (16.6) 9.1 (7.2, 11.4) 4.0 (3.4, 4.6) 22.2
Annual diagnostic volume
  , 100 48 (10.3) 82.5 (75.0, 88.1) 58 (12.1) 6.7 (5.4, 8.4) 3.3 (2.6, 4.1) 17.2
 100–199 72 (15.5) 82.9 (78.8, 86.4) 76 (15.8) 6.8 (5.6, 8.3) 3.7 (3.2, 4.2) 17.3
 200–299 99 (21.3) 84.4 (81.7, 86.9) 102 (21.2) 8.4 (7.3, 9.8) 4.3 (3.7, 4.9) 20.9
 300–499 139 (30.0) 86.2 (83.0, 88.8) 139 (28.9) 9.5 (8.0, 11.1) 4.6 (4.0, 5.3) 22.8
 500–999 54 (11.6) 85.9 (83.6, 88.0) 54 (11.2) 10.5 (9.0, 12.2) 4.6 (3.9, 5.3) 25.3
    1000 52 (11.2) 85.7 (83.0, 88.1) 52 (10.8) 9.8 (7.4, 12.8) 4.1 (3.6, 4.7) 23.7
Screening focus (%)
  , 75 61 (13.2) 86.3 (83.5, 88.7) 62 (12.9) 9.9 (7.4, 13.2) 4.5 (3.8, 5.4) 23.8
 75–79 64 (13.8) 88.8 (85.6, 91.4) 64 (13.3) 11.6 (10.0, 13.4) 5.1 (4.5, 5.8) 27.0
 80–84 119 (25.7) 85.3 (82.5, 87.7) 122 (25.4) 9.7 (8.4, 11.2) 4.2 (3.8, 4.7) 23.6
 85–89 126 (27.2) 84.2 (81.2, 86.7) 133 (27.7) 9.1 (7.8, 10.7) 4.2 (3.7, 4.8) 22.6
    90 94 (20.3) 81.8 (78.1, 85.0) 100 (20.8) 5.6 (4.4, 7.0) 3.4 (2.7, 4.2) 14.5
Note.—Volume represents number of mammograms.
* Data in parentheses are percentages. Seventeen reader-years were not associated with any cancers and therefore did not contribute to the sensitivity estimate.
 † Data in parentheses are 95% CIs.
 ‡ Number of cancers detected per 1000 screening mammograms.
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Basing volume requirements on annual 
screening volume and changing the 
minimum to at least 1000 mammo-
grams would result in 71 110 fewer 
women being recalled, at the expense 
of missing 415 cancers while detecting 
141 413 cancers; and changing the mini-
mum to at least 1500 would result in 
117 187 fewer women being recalled, at 
the expense of missing 361 cancers while 
detecting 141 467 cancers. 
 The direction and clinical interpre-
tation of results did not change after we 
completed the sensitivity analyses de-
scribed above. 
year ( 24–26 ), we found that increasing 
volume requirements could reduce the 
number of work-ups with a very small 
reduction in cancer detection. We esti-
mate that increasing the annual mini-
mum total volume requirements to at 
least 1000 mammograms would result 
in 43 629 fewer women being recalled, 
at the expense of missing 40 cancers 
while detecting 143 215 cancers. Shift-
ing annual total volume requirements 
to at least 1500 mammograms would 
result in 92 838 fewer women being re-
called, at the expense of missing 761 
cancers while detecting 142 494 cancers. 
the high nor the low extreme (mean, 
approximately 1500–4000 mammograms 
per year) for total ( P = .008) and screen-
ing ( P = .015) volumes. Radiologists 
with the lowest diagnostic volume also 
had lower false-positive rates ( P = .004). 
Screening CDR was lower for low-volume 
diagnostic interpreters ( P = .008) and 
for radiologists with greater screen-
ing focus ( P = .002), but did not dif-
fer across total ( P = .30) or screening 
volumes ( P = .56). 
 In our simulation, on the basis of 
an estimated 34 million women aged 
40–79 years undergoing screening each 
 Figure 1 
  
 Figure 1: Graphs show adjusted sensitivity according to interpretive volume, in terms of  (a) total volume,  (b) screening volume,  (c) diagnostic 
volume, and  (d) percentage of total mammograms that represented screening examinations. Sensitivity was adjusted for age and time since 
last mammogram. Lines = regression spline fi t to adjusted rates; dashed lines = 95% CIs; and   = adjusted sensitivity, with size proportional 
to the number of total cancers. Smoothing splines had three knots placed at the 33rd, 50th, and 67th percentiles of the volume distribution; 
estimations were limited to total volume of 6000 or fewer mammograms, screening volume of 5000 or fewer mammograms, diagnostic volume of 
2000 or fewer mammograms, and a screening focus of 65% or greater. Estimated mean adjusted performance is presented graphically, along with 
pointwise 95% CIs, with the curves being interpreted directly as the mean adjusted performance as a function of the volume measure.  P values 
for the estimated curves correspond to omnibus tests of whether there is any association between mean adjusted performance and volume. 
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and statistically important lower rates 
of false-positive results and numbers of 
women recalled per cancer detected—
without a corresponding decrease in 
sensitivity or CDR. We also observed 
lower CDRs in radiologists with low 
diagnostic volumes. Performance across 
radiologists within volume levels had 
wide, unexplained variability, reinforcing 
the ideas that the volume-performance 
relationship is complex and several fac-
tors may infl uence it. 
 Screening performance is unlikely to 
be affected by volume alone, but rather 
evaluated approaches to improving the 
quality of mammographic interpreta-
tion and concluded that data were in-
suffi cient to justify regulatory changes 
to the MQSA volume requirement and 
called for new studies ( 2 ). 
 Our study was designed to examine 
various measures of mammography in-
terpretive volume in relation to screen-
ing performance outcomes. Contrary to 
our expectations, we observed no clear 
association between volume and sensi-
tivity. We found that higher interpretive 
volume was associated with clinically 
 Discussion 
 Current Food and Drug Administration 
regulations state that U.S. physicians 
interpreting mammograms must interpret 
960 mammograms within the previous 
24 months to meet continuing experi-
ence requirements. There has been in-
terest in increasing radiologists’ con-
tinuing experience requirements on the 
assumption that higher volume require-
ments would improve overall interpre-
tive performance, particularly sensitiv-
ity. However, the Institute of Medicine 
 Figure 2 
  
 Figure 2: Graphs show adjusted false-positive rates according to interpretive volume, in terms of  (a) total volume,  (b) screening volume, 
 (c) diagnostic volume, and  (d) percentage of total mammograms that represented screening examinations. False-positive rates were adjusted 
for age and time since last mammogram. Lines = regression spline fi t to adjusted rates; dashed lines = 95% CIs; and   = adjusted false-
positive rate, with size proportional to the number of screening mammograms used to measure performance. Smoothing splines had three 
knots placed at the 33rd, 50th, and 67th percentiles of the volume distribution; estimations were limited to total volume of 6000 or fewer 
mammograms, screening volume of 5000 or fewer mammograms, diagnostic volume of 2000 or fewer mammograms, and a screening 
focus of 65% or greater. Estimated mean adjusted performance is presented graphically, along with pointwise 95% CIs, with the curves being 
interpreted directly as the mean adjusted performance as a function of the volume measure.  P values for the estimated curves correspond to 
omnibus tests of whether there is any association between mean adjusted performance and volume. 
82 radiology.rsna.org n Radiology: Volume 259: Number 1—April 2011
 BREAST IMAGING: Infl uence of Annual Interpretive Volume on Mammography Performance Buist et al
mance measures—for example, recog-
nizing normal and benign variants is im-
portant for false-positive rates, whereas 
detecting subtle cancer fi ndings is im-
portant for sensitivity. Screening is per-
formed to accurately identify indivi-
duals who need additional work-up, 
whereas diagnostic imaging is performed 
to accurately evaluate areas of suspi-
cion. A previous study ( 15 ) found that 
radiologists with a greater  diagnostic fo-
cus have higher screening false-positive 
rates, perhaps because they are more 
accustomed to higher cancer prevalence. 
in offi ce practices where they also in-
terpret other types of imaging studies, 
while designated breast imagers focus on 
screening and diagnostic breast imag-
ing examinations. Although our re sults 
suggest clinically important differ ences 
for radiologists with greater diagnos-
tic volumes, we cannot establish cause 
and effect and did not evaluate the addi-
tional potential infl uence of performing 
interventional procedures. 
 The techniques and skills required 
for interpreting different images differ 
and will also generate different perfor-
by a balance in the interpreted exami-
nation composition. Radiologists with 
greater screening focus had signifi cantly 
lower sensitivities and CDRs and sig-
nifi cantly lower false-positive rates. We 
expected that radiologists  performing 
more diagnostic work-ups would have 
better performance, because of their 
involvement in seeing a case from screen-
ing through work-up, including possible 
involvement with interventional proce-
dures ( 22,28 ). Many large groups de-
centralize their screening: General part-
ners interpret screening mammograms 
 Figure 3 
  
 Figure 3: Graphs show adjusted CDRs according to interpretive volume, in terms of  (a) total volume,  (b) screening volume,  (c) diagnostic 
volume, and  (d) percentage of total mammograms that represented screening examinations. CDRs were adjusted for age and time since last 
mammogram. Lines = regression spline fi t to adjusted rates; dashed lines = 95% CIs; and   = adjusted CDR, with size proportional to the 
number of screening mammograms used to measure performance. Smoothing splines had three knots placed at the 33rd, 50th, and 67th 
percentiles of the volume distribution; estimations were limited to total volume of 6000 or fewer mammograms, screening volume of 5000 or 
fewer mammograms, diagnostic volume of 2000 or fewer mammograms, and a screening focus of 65% or greater. Estimated mean adjusted 
performance is presented graphically, along with pointwise 95% CIs, with the curves being interpreted directly as the mean adjusted perfor-
mance as a function of the volume measure.  P values for the estimated curves correspond to omnibus tests of whether there is any association 
between mean adjusted performance and volume. 
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colleagues with lower volumes. Radiolo-
gists with a greater screening focus had 
signifi cantly lower sensitivities and CDRs 
and signifi cantly lower false-positive rates. 
Recommending any increase in U.S. 
volume requirements will entail crucial 
decisions about the relative importance 
of cancer detection versus false-positive 
examinations and workforce issues, be-
cause changes could curtail workforce 
supply and women’s access to mam-
mography. To achieve higher sensitiv-
ity while lowering false-positive rates, 
further studies need to elucidate the in-
terrelationships between training, expe-
rience, volume, and performance mea-
sures. Several requirements may need 
to be considered simultaneously, such 
as minimum volume in addition to com-
bined minimum performance require-
ments ( 36 ). 
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year, which makes it diffi cult to measure 
sensitivity accurately in this group ( 33 ). 
Additionally, many believe that regular 
feedback improves performance, and 
radiologists who interpret any screen-
ing examination without the opportu-
nity to see the results of their abnormal 
interpretations could not build on that 
experience. We could not explore the 
infl uence of feedback. 
 Breast cancer screening costs 
$3.6 billion annually in the United States 
( 27 ). This does not include the costs 
of false-positive examination work-ups, 
which amount to approximately $1.6 
billion per year, or avoid time, trouble, 
and anxiety for women. Our simula-
tion estimated that the costs of false-
positive fi ndings would be reduced by 
$21.8 and $46.4 million ( 34,35 ) if the 
Food and Drug Administration required 
annual total volume requirements of 
greater than 1000 or fewer than 1500 
mammograms, respectively. Basing vol-
ume requirements on annual screening 
volume and changing the minimum to 
greater than 1000 or fewer than 1500 
mammograms would lower false-positive 
work-up costs by $35.6 million and $58.6 
million, respectively. 
 There is no single “best” performance 
metric that can be used to help set pol-
icy. Our simulation results demonstrate 
that changing MQSA volume require-
ments or adding minimum numbers of 
screening and diagnostic examinations 
could result in modest improvements 
in some screening outcomes at a cost 
to others. An estimated 20% of radiolo-
gists interpret fewer than 1000 mam-
mograms per year, but these account 
for only 6% of all U.S. mammograms 
( 2 ). In our study, 17% of radiologists 
interpreted fewer than 1000 mammo-
grams annually, and 38% interpreted 
fewer than 1500 mammograms annu-
ally. Workforce issues are crucial when 
considering interpretation requirements, 
because raising the minimum number 
of interpretations might cause some 
lower-volume radiologists to stop inter-
preting mammograms. 
 In conclusion, radiologists with higher 
annual volumes had clinically and sta-
tistically signifi cantly lower false-positive 
rates with similar sensitivities as their 
Interpretive volume collection and re-
porting would be required to change if 
volume requirements included minimal 
diagnostic interpretations. 
 The complexity of so many factors 
(eg, years of experience, number of 
cancers interpreted, screening vs diag-
nostic volume, training, and the innate 
skills of the interpreter) will continue 
to challenge researchers and policy-
makers. Does experience at high inter-
pretive volume improve performance, 
or do radiologists who interpret more 
accurately choose to interpret high vol-
umes? Radiologists who take 4 years to 
interpret 5000 screening mammograms 
may vary importantly in performance 
compared with radiologists who at-
tain this volume in 1 year ( 22 ). Sub-
specialty training may also infl uence the 
experience-and-volume interplay. Our 
highest-volume radiologists included a 
mix of some with many years of expe-
rience and newer graduates with fel-
lowship training, and within this group 
were varying volumes of screening and 
diagnostic interpretations. 
 Our results and conclusions are spe-
cifi c to screening performance, which 
comprises 80% of U.S. mammography. 
Whereas most prior studies examined 
only screening, we examined different 
volume measures and collected volume 
across all facilities where radiologists in-
terpreted over 5 years. We modeled the 
association between volume interpreted 
in the prior year with performance in 
the following year, as opposed to includ-
ing future volume measures in associa-
tion with past performance. We based 
performance measures on actual prac-
tice, not test-set performance. 
 Statistical variability issues compli-
cate measuring volume-performance out-
comes. Cancer is rare in screening set-
tings. In our study, radiologists detected 
a mean of 4.2 cancers per 1000 mam-
mograms with a sensitivity of 85.2%. 
Because false-negative cases are rare 
(one per 1000 mammograms) and some 
are visible only in retrospect ( 29–32 ), it 
could take many years for a low-volume 
reader to miss a fi nding that an expert 
might identify. This is a smaller prob-
lem for high-volume readers. Low-volume 
radiologists see only a few cancers each 
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